|
Prostanoic Acids
|
D10.251.740 |
|
|
Sulfatidosis
|
C18.452.648.398.641.803.925 |
|
|
Library Materials
|
L01.583.420 |
|
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2
|
D12.776.476.100.200 |
|
|
Suramin
|
D02.455.426.559.847.638.555.750 |
|
|
Distemper Virus, Phocine
|
B04.820.480.937.600.650.500.320 |
|
|
Ipratropium
|
D03.132.889.180.648.400 |
|
|
Diatomaceous Earth
|
D01.650.550.825.400 |
|
|
Carbuncle
|
C01.800.720.770.270.200 |
|
|
Calcium Aluminosilicate
|
D01.578.725.025.225 |
|
|
Histocompatibility Testing
|
E01.370.225.812.385 |
|
|
Mercury Poisoning, Nervous System
|
C10.720.475.600 |
|
|
Bariatrics
|
D049088 |
[Activities related to WEIGHT REDUCTION in patients with OBESITY. Treatment methods include DIET; EXERCISE; BEHAVIOR MODIFICATION; medications; and BARIATRIC SURGERY.
] |
|
Doxepin
|
D03.633.300.382.393 |
|
|
Dibenzoxepins
|
D03.633.300.382 |
|
|
Auditory Brain Stem Implants
|
E07.814.458.074 |
|
|
Hearing Aids
|
E07.814.458 |
|
|
Cyclin-Dependent Kinase Inhibitor p21
|
D12.776.624.776.355.500 |
|
|
Purchasing, Hospital
|
N04.452.442.452.422.679 |
|
|
Chyle
|
A12.207.270.606.350 |
|
